Latest MS research news

Latest MS research news | 30 July 2013

Iron and neurodegeneration in the multiple sclerosis brain

This study looked at the distribution of non-heme iron as well as the expression of the iron-related proteins ferritin, hephaestin and ceruloplasmin as regards the oxidative damage in the brain tissue of 33 people with MS and 30 controls.

From MSIF

Latest MS research news | 23 July 2013

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

This multicentre, double-blinded, placebo-controlled study looked at dronabinol, a cannabinoid which may have neuroprotective effects on progressive MS.

From MSIF

Latest MS research news | 23 July 2013

Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter

This study assessed the correlation between cortical lesion load on 7T MRI and the magnetisation transfer ratio (MTR) of the normal appearing white matter (NAWM), in order to test the hypothesis that cortical ...

From MSIF

Latest MS research news | 23 July 2013

Multiple sclerosis: identification of temporal changes in brain lesions with computer-assisted detection software

This study from the US looked at the performance of a locally developed computer-assisted detection (CAD) software, which they used to track temporal changes in MS brain lesions.

From MSIF

Latest MS research news | 16 July 2013

Vitamin D levels and risk of MS in patients with CIS

In this retrospective study from Italy the researchers looked at serum 25-hydroxyvitamin D (25(OH)D) levels in people with clinically isolated syndrome (CIS) and the associated risk of MS.

From MSIF

Latest MS research news | 15 July 2013

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

This study group evaluated if IFNB-1b in patients with clinically isolated syndrome (CIS) prevented persisting T1 hypointensities on MRI (persistent black holes (PBHs)).

From MSIF

Latest MS research news | 15 July 2013

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study

This nine-year follow-up study aimed to identify clinical and/or MRI predictors of long-term progression in a large group of people with MS.

From MSIF

Latest MS research news | 09 July 2013

Seven-tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory process

This study from Italy investigated the potential of ultrahigh-field MRI (7 tesla), in particular phase imaging combined with dynamic contrast enhancement, to provide a better insight into acute MS lesions.

From MSIF

Latest MS research news | 09 July 2013

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

This collaborative study looked at determining the relationship of brain lesion load and brain and spinal cord atrophy, with physical disability in patients with a long duration of MS.

From MSIF

Latest MS research news | 09 July 2013

Optic nerve head component responses of the multifocal electroretinogram in MS

This study from the US looked at a new stimulation paradigm in order to elicit multifocal electroretinography (mfERG)-induced optic nerve head component (ONHC) responses.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial